INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $946,844 | +6.8% | 25,405 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $886,380 | -79.9% | 25,405 | -67.8% | 0.00% | -83.3% |
| Q3 2022 | $4,415,000 | +182.1% | 78,897 | +160.9% | 0.01% | +500.0% |
| Q2 2022 | $1,565,000 | -57.9% | 30,236 | +9.1% | 0.00% | -66.7% |
| Q3 2021 | $3,719,000 | -82.4% | 27,722 | -78.7% | 0.00% | -83.3% |
| Q2 2021 | $21,096,000 | +2273.0% | 130,301 | +191.5% | 0.02% | +1700.0% |
| Q3 2020 | $889,000 | +15.0% | 44,700 | +58.0% | 0.00% | 0.0% |
| Q2 2018 | $773,000 | +1785.4% | 28,295 | +1221.0% | 0.00% | – |
| Q4 2017 | $41,000 | – | 2,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |